slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 236,581-236,610
Pages 10,126
Rows per page 30
Component
236,581-236,610 of 303,780
27
The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
28
Clinical trial design slide for a pharmaceutical study.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
31
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
32
The slide uses a series of circles to present key metrics, highlighting the global expenditure figure.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
33
Uses an emotional image of a father and child to emphasize the human impact of the disease.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
34
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
35
Uses a timeline to establish a 'gap' in innovation, followed by three key arguments for why new therapy is needed.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
38
The slide compares AAV8-PM (therapeutic) against AAV8-GFP (control) and an untreated control group.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
39
The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
40
The slide uses a combination of a process description (left) and experimental data (line chart and bar chart) to validate the therapeutic hypothesis.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
41
NHP = Non-Human Primate. STZ likely refers to Streptozotocin, a compound used to induce diabetes in animal models.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
42
ATTD likely refers to the Advanced Technologies & Treatments for Diabetes conference.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
43
The data shows a significant improvement in glucose regulation post-therapy, closely tracking the normal NHP curve.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
44
IHC stands for Immunohistochemistry. The images show DAPI (blue), Insulin (cyan), and Glucagon (red) staining.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
45
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
46
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
47
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
48
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
49
The slide uses a grid layout to present five board members with their respective titles and professional summaries.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
50
The slide uses a column-based layout to track progress across different workstreams.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
51
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
53
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
54
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
55
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
58
The slide outlines the progression of a clinical trial from Phase 1 through Phase 2b.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
01
Includes branding and date context.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations 1 hit
02
Grove | Investor Presentation Deck | 35 slidesGrove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations 1 hit
03
The slide uses a four-pillar structure to summarize financial and operational health.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations 1 hit
06
The slide uses a background image of ocean plastic pollution to establish emotional context.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit